PF

Phillip Frost

North America, Massachusetts, United States, Boston

Description

phillip frost is the Chairman at OPKO Health .

Investor Profile

Phillip Frost has made 4 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series C (50%)
  • Post Ipo Equity (25%)
  • Series Unknown (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Care
  • Medical
  • Pharmaceutical
  • Advertising
  • Internet
  • Marketing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Phillip Frost frequently co-invest with?

LSP BioVentures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Catalyst Fund LP
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
DSC Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Quark Venture
North America, British Columbia, Canada, Vancouver
Co-Investments: 2
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
GF Securities
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
Catalyst Venture Partners
Europe, Bath and North East Somerset, United Kingdom, Bath
Co-Investments: 1
OPKO Health
North America, Florida, United States, Miami
Co-Investments: 1
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2

What are some of recent deals done by Phillip Frost?

Eloxx

Waltham, Massachusetts, United States

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.

BiotechnologyGeneticsHealth Care
Series CAug 2, 2017
Amount Raised: $8,000,000
Eloxx

Waltham, Massachusetts, United States

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.

BiotechnologyGeneticsHealth Care
Series CJun 9, 2017
Amount Raised: $30,000,000
MabVax Therapeutics

San Diego, California, United States

MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityApr 6, 2015
Amount Raised: $11,600,000
5to1

Seattle, Washington, United States

5to1 is an online ad publishing platform enabling media publishers to manage and sell their ad space inventory.

AdvertisingInternetMarketing
Series UnknownNov 10, 2010
Amount Raised: $6,500,000